Senores Pharmaceuticals Live Share Price Today, Share Analysis and Chart

Name: Senores Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Senores Pharmaceuticals Ltd.
Rating: 2.899583375
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

Iran war impact

Senores Pharmaceuticals Ltd. (SENORES) appears to have a minimal to manageable impact from the ongoing conflict and geopolitical tensions in the Middle East. While the company has a presence in the region, its core financial performance is heavil...

783.25 10.95 (1.42%)

64.89% Gain from 52W Low

216.8K

NSE+BSE Volume

NSE 08 Apr, 2026 3:49 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

60.3 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

1,089

1Yr Price target upside is 39%

4 analysts

Senores Pharmaceuticals Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Senores Pharmaceuticals Live Share Price Today, Share Analysis and Chart

Senores Pharmaceuticals Ltd. (SENORES) appears to have a minimal to manageable impact from the ongoing conflict and geopolitical tensions in the Middle East. While the company has a presence in the region, its core financial performance is heavil...

64.89% Gain from 52W Low

SWOT Analysis

Senores Pharmaceuticals Live Price Chart